Metabolic control of induced pluripotency
- PMID: 38274274
- PMCID: PMC10808704
- DOI: 10.3389/fcell.2023.1328522
Metabolic control of induced pluripotency
Abstract
Pluripotent stem cells of the mammalian epiblast and their cultured counterparts-embryonic stem cells (ESCs) and epiblast stem cells (EpiSCs)-have the capacity to differentiate in all cell types of adult organisms. An artificial process of reactivation of the pluripotency program in terminally differentiated cells was established in 2006, which allowed for the generation of induced pluripotent stem cells (iPSCs). This iPSC technology has become an invaluable tool in investigating the molecular mechanisms of human diseases and therapeutic drug development, and it also holds tremendous promise for iPSC applications in regenerative medicine. Since the process of induced reprogramming of differentiated cells to a pluripotent state was discovered, many questions about the molecular mechanisms involved in this process have been clarified. Studies conducted over the past 2 decades have established that metabolic pathways and retrograde mitochondrial signals are involved in the regulation of various aspects of stem cell biology, including differentiation, pluripotency acquisition, and maintenance. During the reprogramming process, cells undergo major transformations, progressing through three distinct stages that are regulated by different signaling pathways, transcription factor networks, and inputs from metabolic pathways. Among the main metabolic features of this process, representing a switch from the dominance of oxidative phosphorylation to aerobic glycolysis and anabolic processes, are many critical stage-specific metabolic signals that control the path of differentiated cells toward a pluripotent state. In this review, we discuss the achievements in the current understanding of the molecular mechanisms of processes controlled by metabolic pathways, and vice versa, during the reprogramming process.
Keywords: cellular reprogramming; embryonic stem cells (ESCs); glycolysis; induced pluripotent stem cells (iPSCs); mitochondria; oxidative phosphorylation (OxPhos); pluripotency; reactive oxygen species (ROS).
Copyright © 2024 Sinenko and Tomilin.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
![FIGURE 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10808704/bin/fcell-11-1328522-g001.gif)
![FIGURE 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10808704/bin/fcell-11-1328522-g002.gif)
Similar articles
-
Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1.Inflamm Regen. 2020 May 12;40:8. doi: 10.1186/s41232-020-00117-8. eCollection 2020. Inflamm Regen. 2020. PMID: 32426078 Free PMC article. Review.
-
Contrasting transcriptome landscapes of rabbit pluripotent stem cells in vitro and in vivo.Anim Reprod Sci. 2014 Sep;149(1-2):67-79. doi: 10.1016/j.anireprosci.2014.05.014. Epub 2014 Jul 1. Anim Reprod Sci. 2014. PMID: 25059199
-
Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.Stem Cells Dev. 2015 Jun 1;24(11):1366-73. doi: 10.1089/scd.2014.0561. Epub 2015 Apr 2. Stem Cells Dev. 2015. PMID: 25590788
-
Mechanisms of the Metabolic Shift during Somatic Cell Reprogramming.Int J Mol Sci. 2019 May 7;20(9):2254. doi: 10.3390/ijms20092254. Int J Mol Sci. 2019. PMID: 31067778 Free PMC article. Review.
-
Mitochondrial regulation in human pluripotent stem cells during reprogramming and β cell differentiation.Front Endocrinol (Lausanne). 2023 Oct 20;14:1236472. doi: 10.3389/fendo.2023.1236472. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37929027 Free PMC article. Review.
Cited by
-
Polyploidy Promotes Hypertranscription, Apoptosis Resistance, and Ciliogenesis in Cancer Cells and Mesenchymal Stem Cells of Various Origins: Comparative Transcriptome In Silico Study.Int J Mol Sci. 2024 Apr 10;25(8):4185. doi: 10.3390/ijms25084185. Int J Mol Sci. 2024. PMID: 38673782 Free PMC article.
References
-
- Armstrong L., Tilgner K., Saretzki G., Atkinson S. P., Stojkovic M., Moreno R., et al. (2010). Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem cells 28 (4), 661–673. 10.1002/stem.307 - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous